Skip to search.
 TSX Down 0.08% TSX Ventures Up 0.73%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
30.36 Down 1.50(4.69%) 9:33AM EST - Nasdaq Real Time Price
Prev Close:31.85
Open:N/A
Bid:29.60 x 500
Ask:32.17 x 400
1y Target Est:48.27
Beta:2.00616
Next Earnings Date: 9-Feb-16SGEN Earnings announcement
Day's Range:30.29 - 31.01
52wk Range:29.31 - 52.33
Volume:23,661
Avg Vol (3m):1,132,710
Market Cap:4.23B
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENDown 4.69%4.23B
IMGNDown 2.09%651.22M
PFEDown 0.90%177.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.95
Quarterly EPS Est (Dec-15) :-0.20
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-1.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback